Active drum ingredients customized chemical Affecting Immune Function Manufacturer beauty polypeptide Biochemical compounds customized chemical Biochemical substance raw material bulk Biochemie Bulk Pharmaceutical chemicals buy polypeptide online China API China GMP China polypeptide manufacturers Cosmetic Peptide Synthesis Free sample Active medicine compounds Global API Global polypeptide Partner High quality Affecting Immune manufacturers Immunomodulator Producer plant Immunosuppressive drugs Factory Liraglutide octreotide Peptide antibiotics FDA/GMP/DMF Manufacturer Peptide APIs Peptide compounds Producer plant Peptide drugs peptide large-scale production polypeptide polypeptide APIs products polypeptide drugs Polypeptide FDA/GMP/DMF Manufacturer polypeptide manufacturers polypeptide medicine industry polypeptide product polypeptide raw material polypeptides polypeptide suppliers Rapamycin FDA/GMP/DMF Manufacturer semaglutide Shengnuo Biotechnology The best China peptide manufacturer Thymofasin
Polypeptide generics
There are more than 80 kinds of peptide drugs on the global market, covering more than 20 billion US dollars market, and more than 150 are conducting clinical trials. Scientists and pharmaceutical companies around the world attach great importance to the future potential of this subdivision field, but efforts still need to be made in China. According to Dr. Guo Jia and public research data, the brief history of diffuse investment is carefully arranged and available for you to read
The global peptide drug market has reached 22 billion US dollars in 2015, accounting for about 2% of the total market share of medical drugs, maintaining a growth rate of about 12%, and reaching US $254 by 2018. There are several large varieties of peptide drugs with the level of more than 1 billion US dollars in the market, such as insulin, glatirel, liraglutide, dulaglutide, arbutin, somaluptide, tripatide, abaparatide, growth hormone, atrial natriuretic peptide, etelcalcetide, etc.
According to the drug delivery data statistics, from the perspective of global regional distribution, North America currently has the largest market share. Due to high drug prices and large patient groups, it is expected that North America will maintain its leading position until 2020.
In China, peptide drugs are limited by process, equipment and technology, and there are few enterprises with large-scale production capacity of chemical synthetic peptide drugs, and the market competition is eased. By searching the CFDA official website database, we find that there are more than 48 polypeptide drugs on the market in China, which are mainly imported brands, and domestic polypeptide drugs are basically imitations of foreign ones The market of old varieties that have passed the patent protection period is not mature.
In recent years, with the rapid rise of a number of domestic pharmaceutical enterprises with the ability of chemical synthesis of peptide drugs, a few pharmaceutical enterprises with large-scale production capacity, represented by Chengdu suno technology, have begun to emerge, but their products are still peptide generic drugs with weak competitiveness. So far, the R & D enterprises focusing on polypeptide innovative drugs in China are still in a relatively blank stage, and only a few polypeptide innovative drug companies, such as mccoort and plaid, are more well-known. The businesses of peptide enterprises are mainly divided into customized peptide, polypeptide cro, beauty polypeptide, polypeptide API, polypeptide generic preparation and polypeptide innovative drug.
Polypeptide drugs may replace more and more existing drugs in the near future and become one of the important directions of new drug research and development of pharmaceutical companies. Polypeptide drugs are one of the hot spots in the field of new drug research in the post genomic era.
New development direction of peptide drugs
In the past, the innovation of polypeptide drugs in China was mostly at the level of preparation, basically focusing on sustained-release technologies such as microspheres. In fact, in recent years, there have been many new technologies in the field of peptide innovative drugs, such as multi-functional peptides, peptide drug coupling drugs, membrane penetrating peptides and so on, which provide strong technical support for peptide innovation.
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
There are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.